Product Information
OLMESARTAN MEDOXOMIL 20 MG TAB is a generic product labeled by Ascend Laboratories, LLC, priced at $0.0805 per EA under NDC 67877044690. Its NADAC has been published 490 times since May 17, 2017.
FDA first approved this application on Apr 24, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877044690
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA206763FDA Approved
4/24/2017
TE Code
AB
On Market Since
4/24/2017
Pharmacological Classes
Price Statistics
The NADAC for OLMESARTAN MEDOXOMIL 20 MG TAB has been published 490 times since May 17, 2017, and over the history we have for it it has declined 97.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0805 per EA |
|---|---|
| All-time high | $3.6921 (Jun 14, 2017) |
| All-time low | $0.0705 (Nov 20, 2024) |
| 52-week high | $0.0813 |
| 52-week low | $0.0732 |
| Median price | $0.1070 |
| Average price | $0.1664 |
| Largest weekly change | -94.5% (Jul 19, 2017) |
| Weeks tracked | 490 |
| Tracking since | May 17, 2017 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ascend Laboratories, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Olmesartan Medoxomil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OLMESARTAN MEDOXOMIL 20 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN MEDOXOMIL 20 MG TAB, manufactured by Ascend Laboratories, LLC, is $0.0805 per EA (NDC 67877044690), effective Sep 30, 2026.
How has the price of OLMESARTAN MEDOXOMIL 20 MG TAB changed over time?
Over the history we have for it, the NADAC for OLMESARTAN MEDOXOMIL 20 MG TAB has declined 97.8%. It has been tracked across 490 weekly CMS publications since May 17, 2017.
What are the highest and lowest recorded NADAC prices for OLMESARTAN MEDOXOMIL 20 MG TAB?
Since May 17, 2017, the NADAC for OLMESARTAN MEDOXOMIL 20 MG TAB has ranged from a low of $0.0705 (Nov 20, 2024) to a high of $3.6921 (Jun 14, 2017), with a median of $0.1070 per EA.
Are there cheaper alternatives to OLMESARTAN MEDOXOMIL 20 MG TAB?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OLMESARTAN MEDOXOMIL 20 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures OLMESARTAN MEDOXOMIL 20 MG TAB?
OLMESARTAN MEDOXOMIL 20 MG TAB (NDC 67877044690) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.